Analysis of intellectual property strategies across different categories of digital therapeutics - Top-Institutions - MDSpire

Analysis of intellectual property strategies across different categories of digital therapeutics

  • By

  • Tomoki Maeda

  • Hiroshi Suzuki

  • Chikako Saotome

  • March 9, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Digital Therapeutics
    • Clinical Research
    • Intellectual Property in Healthcare

  • #2

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Digital Health
    • Biomedical Informatics
    • Intellectual Property Law

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Digital Therapeutics
    • Health Technology Innovation
    • Patent Strategy

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Digital Therapeutics
    • Clinical Trials
    • Healthcare Intellectual Property

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Digital Therapeutics
    • Clinical Innovation
    • Intellectual Property Management

Original Source(s)

Analysis of intellectual property strategies across different categories of digital therapeutics

  • by Tomoki Maeda, Hiroshi Suzuki, Chikako Saotome

  • March 9, 2026

Related Content

Clinical Characteristics and Outcomes of Invasive Pulmonary Aspergillosis in Patients with Influenza Compared to COVID-19: A Retrospective Cohort Analysis

Jonathan Van-Tam on COVID’s Next Phase

Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19

Reporting of Telehealth Implementation in Cystic Fibrosis: Scoping Review Using a Novel Theory-Based Evaluation Lens